Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.
Also called NCT03987711
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 151 participants
- Registry
-
NCT03987711
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Australia, Canada
- Registry status
- Completed
Technical summary
Registry record NCT03987711. Randomized; no masking; primary purpose treatment. Start 2019-12-10 (actual); primary completion 2022-12-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis
- Acronym
- SAFE-D
- Condition
- Atrial Fibrillation
- Condition
- End Stage Renal Failure on Dialysis
- Intervention (Drug)
- Warfarin
- Intervention (Drug)
- Apixaban
- Intervention (Other)
- No oral anticoagulation
- Lead sponsor
- Unity Health Toronto
- Collaborator
- Canadian Institutes of Health Research (CIHR)
- Collaborator
- The George Institute for Global Health (Sydney, Australia)
Record details
- Record id
cardio:ct-nct03987711- Content hash
af3975156b75c6b83983b5dd1edd280ce7884efb5d1bfe876e5e55e7928f9a8c